Author(s):
Ahmed Alkhodri, Shoeb Alahmad, Ramez Roustom
Email(s):
ahmed-emad-alkhodri@wpu.edu.sy
DOI:
10.52711/0974-360X.2025.00391
Address:
Ahmed Alkhodri1,2*, Shoeb Alahmad3, Ramez Roustom4
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Wataniya Private University, Hama, Syria.
2Department of Industrial Pharmacy, LEM Pharma, Pharmaceutical Company, Hama, Syria.
3Department of Analytical Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy, Al-Wataniya Private University, Hama, Syria.
4Department of General Administration, LEM Pharma, Pharmaceutical Company, Hama, Syria.
*Corresponding Author
Published In:
Volume - 18,
Issue - 6,
Year - 2025
ABSTRACT:
Aim of this study was formulation matrix tablets of nimesulide with controlled release (CR) and immediately release (IR), and evaluation the influence of many types and concentrations of polymers on their in vitro release properties. Four formulations F1 – F4 were designed by wet granulation using different types and amount of polymers, and one formulation with immediately release. The CR matrix tablets formulations (F1 – F4) were composed of using different polymers such as, hydroxypropyl methylcellulose (HPMC-?100?), hydroxypropyl methylcellulose (HPMC-?6), hydroxypropyl cellulose high viscosity (HPCh), carboxymethyl cellulose (CMC), ethylcellulose (EC-10 cps), whereas IR tablets formulation (F5) contained sodium lauryl sulfate (SLS), polyvinylpyrrolidone (PVP-?30), microcrystalline cellulose (MCC) and lactose monohydrate. The MCC and PVP-?30 were used in a fixed quantity in all CR formulations. The effect of polymer viscosity and its quantity on nimesulide release from two formulations containing the same polymer was studied. Data drug release in vitro was evaluated in phosphate buffer of pH 7.4 by analytical method. The amount of released nimesulide was calculated by preparing standard series in phosphate medium. In vitro profile release indicated that formulations F1 and F2 controlled the drug release for 18h and 10h respectively. Formulations F3 and F4 released 73.58%, 62.5% of their content during 18h consecutively, thus their effect can last for more than a day. While immediately release formulation F5 released more than 90% of its content within 1h, and more than 75% with 30 minutes. MS Excel was suggested to analyze the dissolution profile data for drug release kinetics such as first order, Zero-order, Higuchi and Korsmeyer–Peppas models. However, formulation (F1) containing (HPMC -?100?) as a matrix former showed drug release as highest correlation coefficient (r2) values obtained when first-order model was applied (r2 = 0.9524). Formulations (F2, F3) containing (HPMC -?6, HPCh and CMC) and IR formulation F5 showed concentration-independent drug release as highest linearity was observed when zero-order model was applied (r2 = 0.9702 - 0.9773 - 0.8747). Whereas, formulation (F4) containing (HPCh and EC) as a matrix former showed the highest correlation coefficient (r2) values when Korsmeyer-peppas model was applied (R2 = 0.9846). Release mechanism of all formulations was Case II relaxation release. This study performed that cellulosic derivatives polymers can be considered ideal components for controlling immediately release of matrix tablets formulation.
Cite this article:
Ahmed Alkhodri, Shoeb Alahmad, Ramez Roustom. Preparation, Development and Analytical Evaluation of Solid Pharmaceutical Dosage Forms of Nimesulide with Controlled Release and Immediately Release. Research Journal of Pharmacy and Technology. 2025;18(6):2725-1. doi: 10.52711/0974-360X.2025.00391
Cite(Electronic):
Ahmed Alkhodri, Shoeb Alahmad, Ramez Roustom. Preparation, Development and Analytical Evaluation of Solid Pharmaceutical Dosage Forms of Nimesulide with Controlled Release and Immediately Release. Research Journal of Pharmacy and Technology. 2025;18(6):2725-1. doi: 10.52711/0974-360X.2025.00391 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-6-44
REFERENCES:
1. Reddy, D. V., and Rao, A. S. A review on oral extended release technology. Research Journal of Pharmacy and Technology. 2015; 8(10): 1454-62. DOI: 10.5958/0974-360X.2015.00261.9
2. Homayun B, et al. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics 2019; 11(3): 129. DOI: https://doi.org/10.3390/pharmaceutics11030129
3. Ali HS, et al. The effect of modified release dosage forms on absorption of medications. Int J of Pharm and Clin Res. 2019; 11(1): 30-33. Available from: https://www.ijpcr.com
4. Usta, D.Y., Incecayir, T. Modeling of In Vitro Dissolution Profiles of Carvedilol Immediate-Release Tablets in Different Dissolution Media. AAPS PharmSciTech. 2022; 23(6): 201. DOI: https://doi.org/10.1208/s12249-022-02355-0
5. Adilakshmi D, et al. Simultaneous Formulation, Estimation and Evaluation of Allopurinol Sustained Release Tablets using various suitable Excipients. Asian Journal of Pharmaceutical Analysis. 2016; 6(3): 155-66. DOI: https://doi.org/10.5958/2231-5675.2016.00025.9
6. Tarapon, K. V., and TRYHUBCHAK, O. V. Development of extended-release formulation based on the quality by design approach. Acta Poloniae Pharmaceutica–Drug Research. 2022; 79(2): 231-244. DOI:10.32383/appdr/148114
7. Gülsün, T., et al. Preparation and characterization of nimesulide containing nanocrystal formulations. Pharmaceutical Development and Technology. 2013; 18(3): 653-659. DOI: 10.3109/10837450.2012.663390
8. Shaikh, M. S. Double coated tablets of Nimesulide for colon targeting. International Journal of Pharmaceutical Sciences and Nanotechnology. 2010; 3(2): 1000-1005. DOI: https://doi.org/10.37285/ijpsn.2010.3.2.14
9. Periasamy, Jayaprakash., et al. Nimesulide and celecoxib inhibits multiple oncogenic pathways in gastric cancer cells. J Cancer Sci Ther. 2013; 5(4): 126-36. DOI: 10.4172/1948-5956.1000198
10. Güngör, T., et al. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects. European Journal of Medicinal Chemistry. 2021; 221: 113566. DOI: https://doi.org/10.1016/j.ejmech.2021.113566
11. Wei, W., et al. Solubility, permeability, anti-inflammatory action and in vivo pharmacokinetic properties of several mechanochemically obtained pharmaceutical solid dispersions of nimesulide. Molecules. 2021; 26(6): 1513. DOI: https://doi.org/10.3390/molecules26061513
12. Rocha, H. V. A., et al. Characterization of nimesulide and development of immediate release tablets. Eclética Química. 2019; 44(3): 20-35. DOI: https://doi.org/10.26850/1678-4618eqj.v44.3.2019.p20-35
13. Pandey, S. K., et al. Formulation and evaluation of floating tablet of nimesulide by direct compression method. Magna Scientia Advanced Research and Reviews. 2024; 10(1): 153-161. DOI: https://doi.org/10.30574/msarr.2024.10.1.0008
14. Yassin, H. A., et al. Preparation and in-vitro evaluation of dyphylline controlled release matrix tablets. Research Journal of Pharmacy and Technology. 2023; 16(9): 4357-4364. DOI: 10.52711/0974-360X.2023.00713
15. Ghayas, S., et al. Influence of different viscosity grade cellulose-based polymers on the development of valsartan controlled release tablets. Polymer Bulletin. 2020; 77: 1281–1306. DOI: https://doi.org/10.1007/s00289-019-02802-2.
16. Ravi, G., et al. Development and Evaluation of oral controlled release tablets of oxybutynin using various polymers. Research Journal of Pharmacy and Technology. 2020; 13(8): 3854-3860. DOI : 10.5958/0974-360X.2020.00682.4
17. Guarnizo-Herrero, V., et al. Study of different chitosan/sodium carboxymethyl cellulose proportions in the development of polyelectrolyte complexes for the sustained release of clarithromycin from matrix tablets. Polymers. 2021; 13(16): 2813. DOI: https://doi.org/10.3390/polym13162813
18. Chen, L., et al. Solubility Profile and Intermolecular Force Analysis of Nimesulide (Form I) in Mono-and Mixed Solvents at Several Temperatures. Journal of Chemical and Engineering Data. 2022; 67(12): 3700-08. DOI:https://doi.org/10.1021/acs.jced.2c00287
19. Liu, X., Zhao, L., Wu, B., and Chen, F. Improving solubility of poorly water-soluble drugs by protein-based strategy: A review. International Journal of Pharmaceutics. 2023; 634: 122704. DOI: https://doi.org/10.1016/j.ijpharm.2023.122704
20. USP 43- NF38 (2020) The United States Pharmacopeial Convention, USA. Available from: https://www.usp.org
21. Jeganath, S., et al. Oral Controlled Drug Delivery System-A Review. Research Journal of Pharmacy and Technology. 2018; 11(2): 797-804. DOI: 10.5958/0974-360X.2018.00151.8
22. Kumari, N., et al. Development and validation of an analytical method for the simultaneous estimation of Etoricoxib and Thiocolchicoside in tablet dosage form by UV Spectrophotometric method. Research Journal of Pharmacy and Technology. 2022; 15(7): 3051-3056. DOI: 10.52711/0974-360X.2022.00510
23. Joseph, Dhanish, and Maria Jose. Preparation of Nimesulide magnetite nanoparticles for targeted drug delivery. Research Journal of Pharmacy and Technology. 2019; 12(10): 4651-56. DOI: 10.5958/0974-360X.2019.00801.1
24. Purcaru SO., et al. Study of nimesulide release from solid pharmaceutical formulations in tween 80 solutions. Curr Health Sci J. 2010 Jan; 36(1):42-9. Epub 2010 Mar 24. PMID: 24778826; PMCID: PMC3945268.
25. Malviya, Teena., et al. "Formulation Evaluation and Characterization of fast Dissolving Tablets of Meloxicam." Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(2): 113-117. DOI : 10.52711/0975-4377.2021.00020
26. Kumar Prevesh., et al. Mouth Dissolving Tablets: A Modern Approach to Delivery of Drug. Research Journal of Pharmacy and Technology. 2020 July; 13(6): 2943-50. DOI : 10.5958/0974-360X.2020.00521.1
27. Rana, Hardik B., et al. Influence of different beverages on disintegration behavior of pain reliever immediate release formulations. Research Journal of Pharmaceutical Dosage Forms and Technology, 2017, 9.1: 29-32. DOI : 10.5958/0975-4377.2017.00006.4
28. Mehra, Preeti, et al. Formulation evaluation and characterization of fast dissolving tablets of Rofecoxib. Research Journal of Topical and Cosmetic Sciences. 2021; 12(1): 60-64. DOI : 10.52711/2321-5844.2021.00009
29. Khiste, R., et al. A Review on Applications of Hydroxy Propyl Methyl Cellulose and Natural polymers for the development of modified release drug delivery systems. Research Journal of Pharmacy and Technology. 2021; 14(2): 1163-70. DOI: 10.5958/0974-360X.2021.00208.0
30. Suslina, S., and Alkhodri, A. Preparation, evaluation and development celecoxib prolonged release (PR) tablets by using cellulose polyacrylic acid-based polymers. Research Journal of Pharmacy and Technology. 2022; 15(4): 1727-1731. DOI: https://dx.doi.org/10.52711/0974-360X.2022.00289
31. Reddy, Y. K., and Akhila, K. Extended Release Matrix Tablets of Nateglinide: Formulation and In vitro Evaluation. Asian Journal of Pharmaceutical Research. 2020; 10(2): 101-104. DOI: 10.5958/2231-5691.2020.00019.2